Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zyg Pharma is a pharmaceutical company specializing in the development and manufacture of topical formulations, including creams, ointments, gels, lotions, and solutions. Originally a subsidiary of the Micro Labs group, the company was acquired by Glenmark Pharmaceuticals in 2015 to bolster its global dermatology portfolio. Zyg Pharma operates a high-capacity manufacturing facility in Pithampur, India, which maintains approvals from major regulatory bodies including the US FDA. The company serves as a key manufacturing hub for dermatological products distributed in international markets. Its expertise lies in complex topical drug delivery systems and large-scale production of skin care medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zyg Pharma.